Literature DB >> 16048798

Progesterone and human placental lactogen inhibit leptin secretion on cultured trophoblast cells from human placentas at term.

Raquel Coya1, Pedro Martul, Jaime Algorta, Ma Angeles Aniel-Quiroga, Ma Angeles Busturia, Rosa Señarís.   

Abstract

The placenta is an important source of leptin production that contributes to the state of hyperleptinemia observed in pregnant women. Moreover, the synthesis of leptin and its receptors by syncytiotrophoblast cells suggests a potential paracrine or autocrine action of leptin in the placenta. In the present study we examined the effect of gestational hormones, human chorionic gonadotropin (hCG), human placental lactogen (hPL), progesterone and estradiol, on in vitro leptin release by human term trophoblast cells in culture. Placentas at term were obtained immediately after delivery from mothers with uncomplicated pregnancies. Leptin levels were measured by enzyme-linked immunosorbent assay in culture media of trophoblasts maintained in monolayer culture for 24, 48 and 72 h with different hormonal treatments or placebo. Treatment with hPL and progesterone led to a time- and dose-dependent decrease in leptin release that was statistically significant after 24 h, with a maximal effect after 72 h of incubation. In contrast, incubation with estradiol and hCG did not have exhibit any effect on leptin secretion at any of the doses and times assayed in this work. The results obtained in this study support that leptin can be considered a gestational hormone implied in the endocrine function of the placenta and that its secretion is at least partially regulated by steroid and peptidic reproductive hormones in trophoblast cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16048798     DOI: 10.1080/09513590500099305

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Serum leptin and ghrelin concentrations of maternal serum, arterial and venous cord blood in healthy and preeclamptic pregnant women.

Authors:  S Aydin; S P Guzel; S Kumru; Suna Aydin; O Akin; E Kavak; I Sahin; M Bozkurt; I Halifeoglu
Journal:  J Physiol Biochem       Date:  2008-03       Impact factor: 4.158

Review 2.  Placental Lactogen as a Marker of Maternal Obesity, Diabetes, and Fetal Growth Abnormalities: Current Knowledge and Clinical Perspectives.

Authors:  Rafał Sibiak; Maurycy Jankowski; Paweł Gutaj; Paul Mozdziak; Bartosz Kempisty; Ewa Wender-Ożegowska
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

Review 3.  Apelin, APJ, and ELABELA: Role in Placental Function, Pregnancy, and Foetal Development-An Overview.

Authors:  Monika Dawid; Ewa Mlyczyńska; Małgorzata Jurek; Natalia Respekta; Karolina Pich; Patrycja Kurowska; Wiktoria Gieras; Tomasz Milewicz; Małgorzata Kotula-Balak; Agnieszka Rak
Journal:  Cells       Date:  2021-12-29       Impact factor: 6.600

4.  Association of serum leptin at 24-28 weeks gestation with initiation and progression of labor in women.

Authors:  Ki'ara K R Branham; Elizabeth Sherman; Mojgan Golzy; Erma Z Drobnis; Laura C Schulz
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

Review 5.  Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

Authors:  Hyun-Seuk Moon; Maria Dalamaga; Sang-Yong Kim; Stergios A Polyzos; Ole-Petter Hamnvik; Faidon Magkos; Jason Paruthi; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2013-03-08       Impact factor: 19.871

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.